Ventyx Biosciences’ chief scientific officer sells $29,682 in inventory By Investing.com
John Nuss, the Chief Scientific Officer of Ventyx Biosciences, Inc. (NASDAQ:VTYX), just lately offered shares of ...
Read more
Tag: Biosciences
Merck buys Prometheus Biosciences for nearly $11bn
Merck has agreed to purchase Prometheus Biosciences for $10.8bn because the US drugmaker bolsters it pipeline ...
Read more
Avidity Biosciences: Combined Information Might Create An Alternative (NASDAQ:RNA)
Ozgu Arslan/iStock through Getty Photos Avidity Biosciences (NASDAQ:RNA) is a scientific stage firm with a novel ...
Read morePremium Content
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.